Tissue repair fabric
View Patent ↗A prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patients living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
1. A prosthesis comprising two or more superimposed, bonded layers of collagenous tissue which have been crosslinked with a crosslinking agent that permits bioremodeling, wherein said collagenous tissue is derived from tunica submucosa of the small intestine separated from the other layers of the small intestine, wherein the prosthesis is non-antigenic, wherein the prosthesis is sterilized, wherein the two or more layers of the prosthesis are completely bioremodelable, and which, when implanted into a mammalian patient, undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted prosthesis is remodeled by the patient's living cells.
2. The prosthesis of claim 1 wherein the shape of said prosthesis is flat, tubular, or complex.
3. The prosthesis of claim 1 wherein said collagenous layers are bonded together by heat welding for a time and under conditions sufficient to effect the bonding of the collagenous tissue layers.
4. The prosthesis of claim 1 wherein said prosthesis is crosslinked with the crosslinking agent 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.
5. The prosthesis of claim 4 wherein sulfo-N-hydroxysuccinimide is added to the crosslinking agent.
6. The prosthesis of claim 4 wherein acetone is added to the crosslinking agent.
7. The prosthesis of claim 1 wherein the prosthesis is sterilized with peracetic acid.
8. The prosthesis of claim 1 , wherein the prosthesis has one or more surfaces and wherein the one or more surfaces of said prosthesis is coated with a collagenous material which acts as a smooth flow surface.
9. The prosthesis of claim 1 wherein said prosthesis further contains pores.
10. The prosthesis of claim 1 wherein said prosthesis is further composed of chopped collagen fibers.
11. The prosthesis of claim 1 wherein said prosthesis is further composed of collagen threads.
12. The prosthesis of claim 11 wherein said collagen threads are arranged to form a felt, a bundle, a wave or a braid.
13. The prosthesis of any claims 10 – 12 wherein said collagen fibers or threads are partially or completely crosslinked.
14. The prosthesis of claim 1 wherein said prosthesis additionally contains an anticoagulant, one or more antibiotics, or one or more growth factors.
15. A method for preparing a prosthesis having two or more superimposed, bonded layers of collagenous tissue, comprising:
(a) bonding two or more collagen layers together using heat welding by heating said collagenous layers for a time and under conditions sufficient to effect the bonding of the collagen layers and to form a prosthesis;
(b) cooling said heated prosthesis; and
(c) crosslinking said prosthesis with a crosslinking agent that permits bioremodeling, wherein said collagenous tissue is derived from tunica submucosa of the small intestine separated from the other layers of the small intestine, wherein said thus formed prosthesis is non-antigenic, and wherein said thus formed prosthesis when implanted into a mammalian patient, undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted prosthesis is remodeled by the patient's living cells;
wherein the collagenous tissue layers are sterilized with peracetic acid before bonding in step (a) or the prosthesis is sterilized after crosslinking in step (c).
16. The method of claim 15 wherein said heat welding is from about 50° C. to about 75° C.
17. The method of claim 15 wherein said cooling is accomplished by quenching.
18. The method of claim 15 wherein said heat welding is accomplished for a time from about 7 minutes to about 24 hours.
19. The method of claim 15 wherein said prosthesis is crosslinked with the crosslinking agent 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.
20. The method of claim 15 wherein said heat welding is from about 60° C. to about 65° C.
21. The method of claim 15 wherein said heat welding is at about 62° C.
22. The method of claim 15 wherein said heat welding is accomplished for a time of about 1 hour.
23. A method of repairing or replacing a damaged tissue comprising implanting a non-antigenic prosthesis in a patient comprising two or more superimposed, bonded layers of collagenous tissue derived from tunica submucosa of the small intestine separated from the other layers of the small intestine which have been sterilized with peracetic acid and crosslinked with a crosslinking agent that permits bioremodeling, wherein two or more layers of the prosthesis are completely bioremodelable, and which, when implanted into a mammalian patient, undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted prosthesis is remodeled by the patient's living cells.
24. A method for preparing a non-antigenic prosthesis prepared from collagenous tissue derived from tunica submucosa of the small intestine separated from the other layers of the small intestine comprising:
(a) sterilizing the collagenous tissue with peracetic acid at a concentration between about 0.01 and 0.3% in water; and
(b) crosslinking said sterilized collagenous tissue with a crosslinking agent that permits bioremodeling;
wherein a prosthesis is formed from two or more superimposed, bonded layers of collagenous tissue, wherein two or more layers of the prosthesis are bioremodelable, and wherein the prosthesis when implanted into a mammalian patient, undergoes controlled bioremodeling occurring with adequate living cell replacement such that the original implanted prosthesis is remodeled by the patient's living cells without eliciting a significant humoral immune response.
25. The method of claim 24 wherein the prosthesis is sterilized with peracetic acid prior to implantation into the mammalian patient.